HUMAN GENOME SCIENCES INC Increase (Decrease) in Accounts Receivable
HUMAN GENOME SCIENCES INC reported Increase (Decrease) in Accounts Receivable of $3.57 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC increase (decrease) in accounts receivable for the quarter ending 2012-06-30 was -$14.17M, a 167.80% decline year-over-year.
- HUMAN GENOME SCIENCES INC increase (decrease) in accounts receivable for the quarter ending 2012-03-31 was $17.73M.
- HUMAN GENOME SCIENCES INC increase (decrease) in accounts receivable for the quarter ending 2011-12-31 was $10.32M, a 59.27% increase year-over-year.
- HUMAN GENOME SCIENCES INC increase (decrease) in accounts receivable for the quarter ending 2011-09-30 was $6.09M, a 497.55% increase year-over-year.
- HUMAN GENOME SCIENCES INC increase (decrease) in accounts receivable for fiscal 2011 was $28.80M, a 1294.00% increase from fiscal 2010.
- HUMAN GENOME SCIENCES INC increase (decrease) in accounts receivable for fiscal 2010 was $2.07M, a 90.17% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC increase (decrease) in accounts receivable for fiscal 2009 was $21.02M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$14.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $3.57M 10-Q · filed 2012-07-26 | $13.89M derived: sum of 3 quarters · filed 2012-07-26 | $19.98M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $17.73M 10-Q · filed 2012-04-26 | $28.05M derived: sum of 2 quarters · filed 2012-04-26 | $34.15M derived: sum of 3 quarters · filed 2012-04-26 | $55.04M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $10.32M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $16.41M derived: sum of 2 quarters · filed 2012-02-28 | $37.31M derived: sum of 3 quarters · filed 2012-07-26 | $28.80M 10-K · filed 2012-02-28 |
| 2011-09-30 | $6.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $26.99M derived: sum of 2 quarters · filed 2012-07-26 | $18.48M 10-Q · filed 2011-10-28 | $24.96M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $20.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $12.39M 10-Q · filed 2012-07-26 | $18.86M derived: sum of 3 quarters · filed 2012-07-26 | $19.89M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | -$8.51M 10-Q · filed 2012-04-26 | -$2.03M derived: sum of 2 quarters · filed 2012-04-26 | -$1.01M derived: sum of 3 quarters · filed 2012-04-26 | -$821.00K derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $7.50M derived: sum of 2 quarters · filed 2012-02-28 | $7.69M derived: sum of 3 quarters · filed 2012-02-28 | $2.07M 10-K · filed 2012-02-28 |
| 2010-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $1.21M derived: sum of 2 quarters · filed 2011-10-28 | -$4.41M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$5.43M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$5.62M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $21.02M 10-K · filed 2012-02-28 |